Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Relationship between hepcidin and ferritin in haemodialysed patients

T. Sedlackova, J. Racek, D. Rajdl, L. Kielberger, J. Eiselt, L. Malanova, V. Babuska,

. 2013 ; 125 (15-16) : 448-52.

Language English Country Austria

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Hepcidin is a key regulator of iron metabolism. It binds to ferroportin and causes the trapping of iron in cells, rendering it unavailable for erythropoiesis. The synthesis of hepcidin is upregulated by high iron stores and inflammation. Haemodialysed patients suffer from anaemia and impaired iron management, the cause of which is multifactorial. Our aim was to describe the relationship between hepcidin and other parameters of iron metabolism, erythropoiesis, and inflammation. PATIENTS, MATERIALS AND METHODS: Complete blood cell counts, hepcidin, parameters of iron metabolism, and inflammation were measured in samples from 164 dialysed patients and 37 control healthy volunteers. Patients were subdivided according to the time of dialysis session. RESULTS: According to the time of haemodialysis, iron levels showed an insignificant tendency for diurnal variability, whereas hepcidin levels were markedly different. Non-parametric correlations showed a weak, but statistically significant correlation between parameters of iron metabolism and inflammation in the entire group of patients. No correlation was found between hepcidin and other biochemical parameters in controls. Non-parametric correlations were also performed in the time subgroups of patients. CONCLUSION: It seems that the influence of inflammation on hepcidin levels in haemodialysed patients is not crucial and other factors (e.g. hepcidin retention) are involved.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064138
003      
CZ-PrNML
005      
20140708084232.0
007      
ta
008      
140704s2013 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00508-013-0388-1 $2 doi
035    __
$a (PubMed)23807042
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Sedlackova, Terezie $u Institute of Clinical Biochemistry and Haematology, Charles University Hospital in Pilsen, Czech Republic.
245    10
$a Relationship between hepcidin and ferritin in haemodialysed patients / $c T. Sedlackova, J. Racek, D. Rajdl, L. Kielberger, J. Eiselt, L. Malanova, V. Babuska,
520    9_
$a BACKGROUND: Hepcidin is a key regulator of iron metabolism. It binds to ferroportin and causes the trapping of iron in cells, rendering it unavailable for erythropoiesis. The synthesis of hepcidin is upregulated by high iron stores and inflammation. Haemodialysed patients suffer from anaemia and impaired iron management, the cause of which is multifactorial. Our aim was to describe the relationship between hepcidin and other parameters of iron metabolism, erythropoiesis, and inflammation. PATIENTS, MATERIALS AND METHODS: Complete blood cell counts, hepcidin, parameters of iron metabolism, and inflammation were measured in samples from 164 dialysed patients and 37 control healthy volunteers. Patients were subdivided according to the time of dialysis session. RESULTS: According to the time of haemodialysis, iron levels showed an insignificant tendency for diurnal variability, whereas hepcidin levels were markedly different. Non-parametric correlations showed a weak, but statistically significant correlation between parameters of iron metabolism and inflammation in the entire group of patients. No correlation was found between hepcidin and other biochemical parameters in controls. Non-parametric correlations were also performed in the time subgroups of patients. CONCLUSION: It seems that the influence of inflammation on hepcidin levels in haemodialysed patients is not crucial and other factors (e.g. hepcidin retention) are involved.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a komorbidita $7 D015897
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ferritiny $x krev $7 D005293
650    _2
$a hepcidiny $x krev $7 D064451
650    _2
$a lidé $7 D006801
650    _2
$a železo $x krev $7 D007501
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nefritida $x krev $x epidemiologie $7 D009393
650    _2
$a prevalence $7 D015995
650    _2
$a dialýza ledvin $x statistika a číselné údaje $7 D006435
650    _2
$a renální insuficience $x krev $x epidemiologie $7 D051437
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Racek, Jaroslav
700    1_
$a Rajdl, Daniel
700    1_
$a Kielberger, Lukas
700    1_
$a Eiselt, Jaromir
700    1_
$a Malanova, Lada
700    1_
$a Babuska, Vaclav
773    0_
$w MED00010762 $t Wiener klinische Wochenschrift $x 1613-7671 $g Roč. 125, č. 15-16 (2013), s. 448-52
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23807042 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140708084522 $b ABA008
999    __
$a ok $b bmc $g 1031622 $s 862870
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 125 $c 15-16 $d 448-52 $i 1613-7671 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...